Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dabis

Showing results (221-230 of 246) with videos related to

Pageof 25
Sort By:
Microbes and Infection|May 18, 2000
Increase in CD3+ CD4- T lymphocytes in patients with AIDS and disseminated Mycobacterium avium-intracellulare complex infection: a prospective study. GECSA. Groupe d'Epidemiologie Clinique du SIDA en AquitaineF Bonnet, L Dequae-Merchadou, J L Taupin, et al.
BMC Public Health|December 13, 2022
Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan AfricaK Sabapathy, L Balzer, J Larmarange, et al.
International Journal of STD & AIDS|June 8, 2001
Stabilization of HIV infection rates in urban Burkina Faso, 1995-1999N Meda, M Cartoux, F Dabis, et al.
HIV Medicine|November 17, 2004
Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002)K Martin, S Lawson-Ayayi, G Miremont-Salamé, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|June 21, 2014
[HIV and pregnancy: 2013 guidelines from the French expert working group]L Mandelbrot, A Berrébi, S Matheron, et al.
European Journal of Preventive Cardiology|April 18, 2015
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis-Møller, Lene Ryom, Colette Smith, et al.
Clinical Pharmacology and Therapeutics|November 7, 2008
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109)D Hirt, S Urien, D K Ekouévi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2001
Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina FasoY Nebié, N Meda, V Leroy, et al.
The Journal of Infectious Diseases|January 7, 2012
Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic strokeS W Worm, D A Kamara, P Reiss, et al.
HIV Medicine|July 19, 2018
Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyC I Hatleberg, L Ryom, A d'Arminio Monforte, et al.
Pageof 25

Showing results (221-230 of 246) with videos related to

Sort By:
Pageof 25
Microbes and Infection|May 18, 2000
Increase in CD3+ CD4- T lymphocytes in patients with AIDS and disseminated Mycobacterium avium-intracellulare complex infection: a prospective study. GECSA. Groupe d'Epidemiologie Clinique du SIDA en AquitaineF Bonnet, L Dequae-Merchadou, J L Taupin, et al.
BMC Public Health|December 13, 2022
Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan AfricaK Sabapathy, L Balzer, J Larmarange, et al.
International Journal of STD & AIDS|June 8, 2001
Stabilization of HIV infection rates in urban Burkina Faso, 1995-1999N Meda, M Cartoux, F Dabis, et al.
HIV Medicine|November 17, 2004
Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002)K Martin, S Lawson-Ayayi, G Miremont-Salamé, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|June 21, 2014
[HIV and pregnancy: 2013 guidelines from the French expert working group]L Mandelbrot, A Berrébi, S Matheron, et al.
European Journal of Preventive Cardiology|April 18, 2015
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis-Møller, Lene Ryom, Colette Smith, et al.
Clinical Pharmacology and Therapeutics|November 7, 2008
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109)D Hirt, S Urien, D K Ekouévi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2001
Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina FasoY Nebié, N Meda, V Leroy, et al.
The Journal of Infectious Diseases|January 7, 2012
Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic strokeS W Worm, D A Kamara, P Reiss, et al.
HIV Medicine|July 19, 2018
Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyC I Hatleberg, L Ryom, A d'Arminio Monforte, et al.
Pageof 25